Table 1.
Clinical-pharmacogenetic model | Metagenomic-based model | |
---|---|---|
| ||
Patients classified as MTX nonresponders or MTX responders | 48.9 | 100 |
True- negative rate | 69 | 83.3 |
True- positive rate | 0 | 78 |
Values are the percent. MTX = methotrexate; RA = rheumatoid arthritis.